Spectral Medical Inc. (EDTXF)
USD 0.57
(-3.03%)
USD 0.57
(-3.03%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 21.76 Million CAD | 49.87% |
| 2022 | 14.51 Million CAD | 94.31% |
| 2021 | 7.47 Million CAD | -15.4% |
| 2020 | 8.83 Million CAD | 405.84% |
| 2019 | 1.74 Million CAD | 187.64% |
| 2018 | 607 Thousand CAD | -4.86% |
| 2017 | 638 Thousand CAD | -50.08% |
| 2016 | 1.27 Million CAD | -57.77% |
| 2015 | 3.02 Million CAD | -0.53% |
| 2014 | 3.04 Million CAD | -18.71% |
| 2013 | 3.74 Million CAD | 85.98% |
| 2012 | 2.01 Million CAD | 17.52% |
| 2011 | 1.71 Million CAD | 10.59% |
| 2010 | 1.54 Million CAD | -57.79% |
| 2009 | 3.66 Million CAD | 20.86% |
| 2008 | 3.03 Million CAD | 19.59% |
| 2007 | 2.53 Million CAD | 8.1% |
| 2006 | 2.34 Million CAD | -77.11% |
| 2005 | 10.25 Million CAD | -3.97% |
| 2004 | 10.67 Million CAD | 4.68% |
| 2003 | 10.2 Million CAD | 3.18% |
| 2002 | 9.88 Million CAD | 29.38% |
| 2001 | 7.64 Million CAD | 10.74% |
| 2000 | 6.9 Million CAD | 9.52% |
| 1999 | 6.3 Million CAD | 57.5% |
| 1998 | 4 Million CAD | 17.65% |
| 1997 | 3.4 Million CAD | 54.55% |
| 1996 | 2.2 Million CAD | 37.5% |
| 1995 | 1.6 Million CAD | 77.78% |
| 1994 | 900 Thousand CAD | 28.57% |
| 1993 | 700 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 25.03 Million CAD | 15.03% |
| 2024 Q2 | 32.91 Million CAD | 31.51% |
| 2023 Q3 | 18.86 Million CAD | 38.64% |
| 2023 Q2 | 13.6 Million CAD | 2.45% |
| 2023 Q4 | 21.76 Million CAD | 15.33% |
| 2023 FY | 21.76 Million CAD | 49.87% |
| 2023 Q1 | 13.28 Million CAD | -8.51% |
| 2022 Q4 | 14.51 Million CAD | 95.91% |
| 2022 Q1 | 7.48 Million CAD | 0.16% |
| 2022 Q2 | 6.96 Million CAD | -7.0% |
| 2022 Q3 | 7.41 Million CAD | 6.48% |
| 2022 FY | 14.51 Million CAD | 94.31% |
| 2021 Q4 | 7.47 Million CAD | -0.56% |
| 2021 Q1 | 8.61 Million CAD | -2.43% |
| 2021 Q2 | 7.52 Million CAD | -12.67% |
| 2021 Q3 | 7.51 Million CAD | -0.15% |
| 2021 FY | 7.47 Million CAD | -15.4% |
| 2020 Q2 | 9.95 Million CAD | -4.71% |
| 2020 Q3 | 8.64 Million CAD | -13.12% |
| 2020 FY | 8.83 Million CAD | 405.84% |
| 2020 Q1 | 10.44 Million CAD | 498.34% |
| 2020 Q4 | 8.83 Million CAD | 2.12% |
| 2019 Q1 | 1.57 Million CAD | 159.31% |
| 2019 Q3 | 1.58 Million CAD | 13.66% |
| 2019 Q4 | 1.74 Million CAD | 9.88% |
| 2019 FY | 1.74 Million CAD | 187.64% |
| 2019 Q2 | 1.39 Million CAD | -11.18% |
| 2018 FY | 607 Thousand CAD | -4.86% |
| 2018 Q2 | 614 Thousand CAD | 18.76% |
| 2018 Q3 | 470 Thousand CAD | -23.45% |
| 2018 Q1 | 517 Thousand CAD | -18.97% |
| 2018 Q4 | 607 Thousand CAD | 29.15% |
| 2017 Q4 | 638 Thousand CAD | -24.5% |
| 2017 FY | 638 Thousand CAD | -50.08% |
| 2017 Q3 | 845 Thousand CAD | -25.81% |
| 2017 Q2 | 1.13 Million CAD | 28.12% |
| 2017 Q1 | 889 Thousand CAD | -30.44% |
| 2016 FY | 1.27 Million CAD | -57.77% |
| 2016 Q2 | 3.49 Million CAD | 16.59% |
| 2016 Q4 | 1.27 Million CAD | -50.48% |
| 2016 Q3 | 2.58 Million CAD | -26.09% |
| 2016 Q1 | 2.99 Million CAD | -1.02% |
| 2015 Q4 | 3.02 Million CAD | 4.92% |
| 2015 FY | 3.02 Million CAD | -0.53% |
| 2015 Q3 | 2.88 Million CAD | 0.95% |
| 2015 Q2 | 2.85 Million CAD | 14.46% |
| 2015 Q1 | 2.49 Million CAD | -17.95% |
| 2014 Q3 | 2.55 Million CAD | -22.9% |
| 2014 Q4 | 3.04 Million CAD | 18.87% |
| 2014 FY | 3.04 Million CAD | -18.71% |
| 2014 Q1 | 3.18 Million CAD | -14.94% |
| 2014 Q2 | 3.31 Million CAD | 4.27% |
| 2013 FY | 3.74 Million CAD | 85.98% |
| 2013 Q3 | 2.55 Million CAD | 29.22% |
| 2013 Q4 | 3.74 Million CAD | 46.63% |
| 2013 Q2 | 1.97 Million CAD | 13.12% |
| 2013 Q1 | 1.74 Million CAD | -13.22% |
| 2012 FY | 2.01 Million CAD | 17.52% |
| 2012 Q4 | 2.01 Million CAD | 31.25% |
| 2012 Q2 | 1.73 Million CAD | 1.94% |
| 2012 Q3 | 1.53 Million CAD | -11.69% |
| 2012 Q1 | 1.7 Million CAD | -0.53% |
| 2011 Q3 | 1.23 Million CAD | -6.39% |
| 2011 Q4 | 1.71 Million CAD | 39.07% |
| 2011 Q1 | 958 Thousand CAD | -38.11% |
| 2011 FY | 1.71 Million CAD | 10.59% |
| 2011 Q2 | 1.31 Million CAD | 37.27% |
| 2010 Q1 | 2.33 Million CAD | -36.27% |
| 2010 FY | 1.54 Million CAD | -57.79% |
| 2010 Q4 | 1.54 Million CAD | -31.5% |
| 2010 Q2 | 2.15 Million CAD | -7.87% |
| 2010 Q3 | 2.26 Million CAD | 4.97% |
| 2009 Q4 | 3.66 Million CAD | 31.29% |
| 2009 Q3 | 2.79 Million CAD | -4.87% |
| 2009 FY | 3.66 Million CAD | 20.86% |
| 2009 Q2 | 2.93 Million CAD | -8.51% |
| 2009 Q1 | 3.2 Million CAD | 5.77% |
| 2008 Q3 | 2.62 Million CAD | -6.36% |
| 2008 Q4 | 3.03 Million CAD | 15.76% |
| 2008 FY | 3.03 Million CAD | 19.59% |
| 2008 Q2 | 2.79 Million CAD | 9.81% |
| 2008 Q1 | 2.54 Million CAD | 0.47% |
| 2007 Q2 | 2.27 Million CAD | -0.39% |
| 2007 Q4 | 2.53 Million CAD | -3.13% |
| 2007 Q1 | 2.28 Million CAD | 0.0% |
| 2007 FY | 2.53 Million CAD | 8.1% |
| 2007 Q3 | 2.61 Million CAD | 15.27% |
| 2006 FY | 2.34 Million CAD | -77.11% |
| 2006 Q3 | 2.51 Million CAD | -5.66% |
| 2006 Q2 | 2.66 Million CAD | -75.35% |
| 2006 Q1 | 10.82 Million CAD | -1.45% |
| 2005 FY | 10.25 Million CAD | -3.97% |
| 2005 Q4 | 10.97 Million CAD | 4.71% |
| 2005 Q1 | 10.25 Million CAD | 1.51% |
| 2005 Q2 | 10.26 Million CAD | 0.15% |
| 2005 Q3 | 10.48 Million CAD | 2.11% |
| 2004 Q3 | 10.25 Million CAD | -2.34% |
| 2004 Q2 | 10.5 Million CAD | -1.62% |
| 2004 Q4 | 10.1 Million CAD | -1.54% |
| 2004 FY | 10.67 Million CAD | 4.68% |
| 2004 Q1 | 10.67 Million CAD | 3.51% |
| 2003 Q1 | 10.2 Million CAD | -11.0% |
| 2003 FY | 10.2 Million CAD | 3.18% |
| 2003 Q4 | 10.31 Million CAD | 191.06% |
| 2003 Q3 | 3.54 Million CAD | -61.34% |
| 2003 Q2 | 9.16 Million CAD | -10.12% |
| 2002 Q4 | 11.46 Million CAD | -0.51% |
| 2002 Q2 | 9.04 Million CAD | -8.52% |
| 2002 Q1 | 9.88 Million CAD | 3.83% |
| 2002 FY | 9.88 Million CAD | 29.38% |
| 2002 Q3 | 11.52 Million CAD | 27.38% |
| 2001 Q2 | 8.82 Million CAD | 15.48% |
| 2001 Q1 | 7.64 Million CAD | 7.2% |
| 2001 Q3 | 8.78 Million CAD | -0.43% |
| 2001 Q4 | 9.52 Million CAD | 8.37% |
| 2001 FY | 7.64 Million CAD | 10.74% |
| 2000 Q3 | 7.4 Million CAD | 8.93% |
| 2000 FY | 6.9 Million CAD | 9.52% |
| 2000 Q2 | 6.8 Million CAD | -1.45% |
| 2000 Q4 | 7.12 Million CAD | -3.77% |
| 2000 Q1 | 6.9 Million CAD | 9.52% |
| 1999 Q1 | 6.3 Million CAD | -7.35% |
| 1999 Q4 | 6.3 Million CAD | 5.0% |
| 1999 FY | 6.3 Million CAD | 57.5% |
| 1999 Q3 | 6 Million CAD | -7.69% |
| 1999 Q2 | 6.5 Million CAD | 3.17% |
| 1998 Q3 | 7.5 Million CAD | 70.45% |
| 1998 Q2 | 4.4 Million CAD | 10.0% |
| 1998 FY | 4 Million CAD | 17.65% |
| 1998 Q4 | 6.8 Million CAD | -9.33% |
| 1998 Q1 | 4 Million CAD | 8.11% |
| 1997 Q3 | 3.2 Million CAD | 3.23% |
| 1997 Q4 | 3.7 Million CAD | 15.63% |
| 1997 Q1 | 3.4 Million CAD | 88.89% |
| 1997 FY | 3.4 Million CAD | 54.55% |
| 1997 Q2 | 3.1 Million CAD | -8.82% |
| 1996 Q2 | 2.2 Million CAD | 0.0% |
| 1996 Q3 | 2.2 Million CAD | 0.0% |
| 1996 FY | 2.2 Million CAD | 37.5% |
| 1996 Q1 | 2.2 Million CAD | 22.22% |
| 1996 Q4 | 1.8 Million CAD | -18.18% |
| 1995 Q2 | 2.4 Million CAD | 50.0% |
| 1995 Q4 | 1.8 Million CAD | 12.5% |
| 1995 FY | 1.6 Million CAD | 77.78% |
| 1995 Q1 | 1.6 Million CAD | 45.45% |
| 1995 Q3 | 1.6 Million CAD | -33.33% |
| 1994 Q2 | 1.2 Million CAD | 33.33% |
| 1994 Q1 | 900 Thousand CAD | 0.0% |
| 1994 FY | 900 Thousand CAD | 28.57% |
| 1994 Q4 | 1.1 Million CAD | 37.5% |
| 1994 Q3 | 800 Thousand CAD | -33.33% |
| 1993 FY | 700 Thousand CAD | 0.0% |
| 1993 Q1 | 700 Thousand CAD | 37.03% |
| 1992 Q4 | 510.83 Thousand CAD | -18.12% |
| 1992 Q2 | 598.08 Thousand CAD | 0.0% |
| 1992 Q3 | 623.91 Thousand CAD | 4.32% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -503.104% |
| Arrayit Corporation | 7.49 Million USD | -190.265% |
| Atlantic International Corp. | 3.82 Million USD | -468.351% |
| Biocept, Inc. | 22.01 Million USD | 1.149% |
| Bioqual, Inc. | 18.93 Million USD | -14.901% |
| CardioGenics Holdings Inc | 1.79 Million USD | -1112.308% |
| DermTech, Inc. | 64.75 Million USD | 66.396% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 97.039% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -75.683% |
| iMD Companies, Inc. | 1.67 Million USD | -1199.713% |
| IDenta Corp. | 1.01 Million USD | -2047.74% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 22.719% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -7203.312% |
| InVitro International | 78.99 Thousand USD | -27447.791% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | -10.294% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -16729.47% |
| Medical Imaging Corp. | 9.51 Million USD | -128.641% |
| NovelStem International Corp. | 4.2 Million USD | -417.346% |
| Optigenex Inc. | 9.57 Million USD | -127.363% |
| PharmChem, Inc. | 558.64 Thousand USD | -3795.125% |
| Proteome Sciences plc | 18.48 Million USD | -17.691% |
| Response Genetics, Inc | 15.86 Million USD | -37.14% |
| Rennova Health, Inc. | 49.66 Million USD | 56.189% |
| RushNet, Inc. | 6.23 Million USD | -248.774% |
| ScreenPro Security Inc. | 1.6 Million USD | -1259.501% |
| Stella Diagnostics Inc. | 18 Million USD | -20.853% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -165.237% |
| Todos Medical Ltd. | 50.15 Million USD | 56.616% |